PT  - JOURNAL ARTICLE
AU  - Karakuzu, Agah
AU  - Appelhoff, Stefan
AU  - Auer, Tibor
AU  - Boudreau, Mathieu
AU  - Feingold, Franklin
AU  - Khan, Ali R.
AU  - Lazari, Alberto
AU  - Markiewicz, Chris
AU  - Mulder, Martijn
AU  - Phillips, Christophe
AU  - Salo, Taylor
AU  - Stikov, Nikola
AU  - Whitaker, Kirstie
AU  - de Hollander, Gilles
TI  - qMRI-BIDS: an extension to the brain imaging data structure for quantitative magnetic resonance imaging data
AID  - 10.1101/2021.10.22.21265382
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.10.22.21265382
4099  - http://medrxiv.org/content/early/2021/10/26/2021.10.22.21265382.short
4100  - http://medrxiv.org/content/early/2021/10/26/2021.10.22.21265382.full
AB  - The Brain Imaging Data Structure (BIDS) established community consensus on the organization of data and metadata for several neuroimaging modalities. Traditionally, BIDS had a strong focus on functional magnetic resonance imaging (MRI) datasets and lacked guidance on how to store multimodal structural MRI datasets. Here, we present and describe the BIDS Extension Proposal 001 (BEP001), which adds a range of quantitative MRI (qMRI) applications to the BIDS application sphere. In general, the aim of qMRI is to characterize brain microstructure by quantifying the physical MR parameters of the tissue via computational, biophysical models. By proposing this new standard, we envision standardization of qMRI which makes multicenter dissemination of interoperable data possible. As a result, BIDS can act as a catalyst of convergence between qMRI methods development and application-driven neuroimaging studies that can help develop quantitative biomarkers for neural tissue characterization. Finally, our BIDS extension offers a common ground for developers to exchange novel imaging data and tools, reducing the practical barriers to standardization that is currently lacking in the field of neuroimaging.Competing Interest StatementThe authors have declared no competing interest.Funding StatementBiotechnology and Biological Sciences Research Council, London (BB/S008314/1). F.R.S.-FNRS, Belgium. Rubicon grant from the Dutch Research Council (NWO. Canada First Research Excellence Fund through the TransMedTech Institute, Canadian Open Neuroscience Platform (CONP) and International Society for Magnetic Resonance in Medicine (ISMRM).Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:N/AI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.Yeshttps://github.com/bids-standard/bids-examples https://doi.org/10.17605/OSF.IO/K4BS5